TELA Bio, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
TELA Bio, Inc. (TELA) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$20.76 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-11-12
- TELA Bio, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-09-30 was -$6.66M.
- TELA Bio, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-06-30 was -$5.54M, a 112.57% decline year-over-year.
- TELA Bio, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was -$8.56M.
- TELA Bio, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-09-30 was -$4.00M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2021-09-30 | -$6.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$12.19M derived: sum of 2 quarters · filed 2021-11-12 | -$20.76M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$14.10M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$8.56M 10-Q · filed 2021-05-14 | ||
| 2020-09-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $40.06M derived: sum of 2 quarters · filed 2021-11-12 | $36.16M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $44.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $40.17M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | -$3.89M 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |